Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis

• Status: Completed
• Trial end date: 2018-03-23
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate the efficacy, safety, and dose-response relationship of KLH-2109 compared to placebo in Japanese patients with endometriosis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kissei Pharmaceutical Co., Ltd.
• Treatments: Leuprolide

Criteria

Inclusion Criteria:

• Female patients with endometriosis

Exclusion Criteria:

• Patients with clinically significant hepatic, renal, or cardiovascular dysfunction